Pioglitazone Hydrochloride and Metformin Hydrochloride - pioglitazone hydrochloride and metformin hydrochloride
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-1550 |
| Proprietary Name: | Pioglitazone Hydrochloride and Metformin Hydrochloride |
| Suffix: | |
| Non-Proprietary Name: | pioglitazone hydrochloride and metformin hydrochloride |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 17-08-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA090406 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Active Numerator Strength: | 500; 15 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| DEA Schedule: |